In Martinique, een Frans grondgebied in het Caribisch gebied, trekken toeristen massaal naar kristalheldere watervallen die zich nestelen in de ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...

Rumble Inc. (RUM) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.14 per share a year ago. These figures are ...

Hengrui Pharma signed the agreement with Merck (NYSE: MRK) — known as MSD outside of the United States and Canada — for HRS-5346, its investigational oral small molecule Lipoprotein(a), or Lp ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Als jonge ambitieuze manager vertoonde ze kopieergedrag en was ze hard, ‘harder dan ik ben’. Met behulp van een coach leerde ze naar haar gevoel te luisteren en dingen niet meer weg te stoppen. Nu ...

Koningshuisdeskundige en journalist Phil Dampier zegt hierover tegen The Sun: „Niets gebeurt per ongeluk, ze heeft dit waarschijnlijk volledig doordacht. Ze weet dat een foto van haar kinderen ...

Merck & Co. (MRK) releases positive phase three data for its injectable-form cancer drug Keytruda. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the ...